The researchers said that their deep-learning interpreter of outcomes for patients with gliomas could be more accurate and objective than pathologists.
The firm's transplant allograft status test identifies genetic biomarkers that predict the likelihood of a patient's immune system to reject the organ over time.
Researchers from Northwestern University uncovered five circulating microRNAs that differentiate patients with very high- and low-risk prostate cancer.
